Navigation Links
Avanir Pharmaceuticals Announces Enrollment of First Patient in Study of AVP-923 for the Treatment of Levodopa Induced Dyskinesia in Parkinson's Disease
Date:10/22/2013

ALISO VIEJO, Calif., Oct. 22, 2013 /PRNewswire/ -- Avanir Pharmaceuticals, Inc. (NASDAQ: AVNR) today announced the enrollment of the first patient in study AVR-133. The study is a proof of concept, Phase II clinical trial investigating the use of AVP-923 for the treatment of levodopa induced dyskinesia (LID) in patients with Parkinson's disease (PD).

(Logo: http://photos.prnewswire.com/prnh/20130207/LA55901LOGO)

"This is an important study of a compound with multifaceted pharmacology for the management of levodopa induced dyskinesia in Parkinson's disease," said Anthony E. Lang, MD, Professor and Director of the Division of Neurology and Chair for Parkinson's Disease Research at the University of Toronto. "Despite advances in PD therapeutics, many patients still suffer with poorly controlled dyskinesias, especially as they require higher doses of medications to increase dopamine levels. Dyskinesias can not only be disabling but may also limit the dose of effective medications that treat core symptoms of PD."

Top line data for this study is expected in the second half of calendar 2014.

About the Study

This proof-of-concept, double blind, randomized, crossover study will compare AVP-923 (45 mg of dextromethorphan / 10 mg of quinidine) with placebo for treatment of LID. The study will enroll approximately 16 PD patients across three study centers in the US and Canada. Study participants will receive, in a random order, a 2-week treatment with AVP-923 and a 2-week placebo treatment, separated by a 2-week break. At the end of each 2-week treatment period, patients will receive a 2-hour levodopa infusion to test the drug effect on dyskinesia. Patients will be carefully monitored throughout the 6-week
'/>"/>

SOURCE Avanir Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Avanir Pharmaceuticals Announces Publication of AVP-825 Pharmacokinetic Data in Journal "Headache"
2. Avanir Pharmaceuticals Announces Settlement of NUEDEXTA Patent Litigation with Wockhardt
3. Avanir Pharmaceuticals Announces Settlement of NUEDEXTA Patent Litigation with Actavis
4. Avanir Pharmaceuticals Announces Publication of PRISM Pseudobulbar Affect Registry Findings
5. Avanir Pharmaceuticals Announces Settlement of NUEDEXTA Patent Litigation with Sandoz
6. Avanir Pharmaceuticals Announces Diabetes Co-Promotion Agreement with Merck
7. Avanir Pharmaceuticals Reports Fiscal 2013 Third Quarter Financial and Business Results
8. Avanir Pharmaceuticals to Participate in Two Conferences in August
9. Avanir Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
10. Avanir Pharmaceuticals Announces Accelerated Development Path for AVP-786 Following Successful Pre-IND Meeting with FDA
11. Avanir Pharmaceuticals to Participate in Two Upcoming Investor Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/17/2014)... Pa. , Sept. 17, 2014  Auxilium Pharmaceuticals, ... company, today confirmed that Auxilium has received an unsolicited, ... ENDP ) to acquire all of the outstanding shares ... per share in cash and Endo stock, subject to ... the unsolicited, non-binding proposal that Auxilium received from Endo ...
(Date:9/16/2014)... Massachusetts , 17 settembre 2014 ... annunciato oggi il lancio in Europa del Tomcat, ... Tomcat è una piattaforma multifunzionale completamente automatizzata, progettata ... le inefficienze ed i rischi di errore legati ... automazione dello strumento Tomcat di Hologic riduce il ...
(Date:9/16/2014)... 3SBio Inc., ("3SBio") a leading biotechnology ... focusing on researching, developing, manufacturing and marketing biopharmaceutical ... an exclusive license agreement with JenKem Technology Co., ... in Mainland China of PEG-irinotecan, a long-acting polymer-drug ... over-expressed in many solid tumors, including colorectal, ovarian, ...
Breaking Medicine Technology:Auxilium Responds To Unsolicited Proposal From Endo International 2Auxilium Responds To Unsolicited Proposal From Endo International 3Auxilium Responds To Unsolicited Proposal From Endo International 4Auxilium Responds To Unsolicited Proposal From Endo International 5Auxilium Responds To Unsolicited Proposal From Endo International 6Auxilium Responds To Unsolicited Proposal From Endo International 7Hologic annuncia il lancio dello strumento preanalitico Tomcat in Europa 2Hologic annuncia il lancio dello strumento preanalitico Tomcat in Europa 33SBio Inc. obtains exclusive licenses to develop and market JenKem's PEG-Irinotecan in China 23SBio Inc. obtains exclusive licenses to develop and market JenKem's PEG-Irinotecan in China 33SBio Inc. obtains exclusive licenses to develop and market JenKem's PEG-Irinotecan in China 43SBio Inc. obtains exclusive licenses to develop and market JenKem's PEG-Irinotecan in China 5
... GlaxoSmithKline (NYSE: GSK ) confirmed today that a joint ... allow Avandia to remain on the market. Committee members voted for recommendations ... label with additional warnings and restrictions (20) to withdrawal from the U.S. ... , ...
... Services announced today  that the American Board of Radiology (ABR) has qualified ... therapy--as a Practice Quality Improvement (PQI) for the purpose of Maintenance of ... , With ... audit of their beam data through the use of a web portal: ...
Cached Medicine Technology:GlaxoSmithKline Statement in Response to FDA Advisory Committees' Vote on Safety of Avandia® (rosiglitazone) 2GlaxoSmithKline Statement in Response to FDA Advisory Committees' Vote on Safety of Avandia® (rosiglitazone) 3GlaxoSmithKline Statement in Response to FDA Advisory Committees' Vote on Safety of Avandia® (rosiglitazone) 4eDataAudit Receives Approval from the American Board of Radiology 2
(Date:9/17/2014)... PROVIDENCE, R.I. [Brown University] Right now no one ... with bipolar disorder, but in a new article in ... survey responses they gathered from scores of people with ... suggests is that yoga can be a substantial help, ... no scientific literature on hatha yoga for bipolar disorder," ...
(Date:9/17/2014)... 2014 Fresh off their High Times ... its support of The Silver Tour, an educational non-profit ... many benefits of medical marijuana. , Florida Buds, a ... marijuana dispensary and treatment center, donated $1,000.00 ... to launch a statewide radio campaign in advance of ...
(Date:9/17/2014)... (PRWEB) September 17, 2014 DMG ... Ed Begley, Jr., scheduled to broadcast on Wednesday, ... Discovery Channel. , In this episode, Innovations will ... of Freedom’s mission to provide each client the ... spiritual well being; using the principles of Care, ...
(Date:9/17/2014)... (PRWEB) September 17, 2014 Angeldress.co.uk ... kinds of graceful special occasion outfits for worldwide clients. ... officials are thinking of opening the first flagship retail ... fashion industry. Recently, the company has unveiled its new ... promotion. , All its new products are offered ...
(Date:9/17/2014)... For electronic publishing expert eBooks2go, working with ... a miraculous connection and precision timing. This experienced wordsmith ... over the past three decades, Ms. Wixom has produced ... it rather tedious to expand her readership inside a ... call, an anniversary, and a second-place trophy changed all ...
Breaking Medicine News(10 mins):Health News:Survey finds benefits, risks of yoga for bipolar disorder 2Health News:Survey finds benefits, risks of yoga for bipolar disorder 3Health News:Florida Buds Supports Silver Tour 2Health News:Innovations to Explore Substance Abuse and Mental Health in Upcoming Episode Airing Wednesday, September 24, 2014 via Discovery Channel. 2Health News:Angeldress.co.uk Is Planning To Open Its First Retail Store And Offering Big Savings On Amazing Wedding Dresses 2Health News:Versatile Author Wixom Forges Lasting Relationship with Digital Virtuoso eBooks2go 2Health News:Versatile Author Wixom Forges Lasting Relationship with Digital Virtuoso eBooks2go 3Health News:Versatile Author Wixom Forges Lasting Relationship with Digital Virtuoso eBooks2go 4
... have long thought that limiting the calories a person consumes ... cancers. But research using mice suggests// that body composition ... is key to reducing cancer risks. ,In ... important to controlling cancer risks than how many or how ...
... American biologist has developed a backpack that reduces the weight ... by Lawrence Rome, a biology professor at the University of ... emergency workers, reported UPI news wire. ,It uses ... the burden of weight. The cords suspend the load at ...
... to a study published in the the journal SLEEP, ... depressive symptoms// and comorbid anxiety disorders compared with children ... most effective care, parents of sleep-disturbed children are advised ... issue a referral to a sleep specialist for comprehensive ...
... marine snail have gotten an unprecedented look at brain mechanisms, ... creature are far from sluggish. ,At any given time ... as Aplysia, more than 10,000 genes are active, according to ... journal Cell. The findings suggest that acts of learning or ...
... In hemophilia, a mutated gene prevents the production of ... such genetic diseases, when they exist//, may consist of ... what if the body could be induced to begin ... the abilities that are lacking? ,Prof. Yair Reisner ...
... at Purdue University have used a new technique ... dangerous E. coli, without time-consuming// treatments usually required. ... DESI, could be used to create a new ... from food safety to homeland security, said R. ...
Cached Medicine News:Health News:Body Composition Is Key Player in Controlling Cancer Risks 2Health News:Link Between Insomnia and Hypersomnia, Depression in Children 2Health News:How Many Genes Does It Take to Learn? Lessons from Sea Slugs 2Health News:How Many Genes Does It Take to Learn? Lessons from Sea Slugs 3Health News:A Transplant in Time - Scientists ID Window for Tissue Transplant 2Health News:New Technique to Identify Bacteria for Food Safety 2Health News:New Technique to Identify Bacteria for Food Safety 3
... Multifunctional instrumentation, capable of ... tissue by means of ultra-sonic ... on organs, and, in particular, ... advantages of tissue-selection and non-traumatic ...
... expect from the long-established Selector Ultrasonic ... integrated circuitry and the small, ergonomic ... surgical techniques, ultrasonic surgery selectively dissects ... as nerves and blood vessels relatively ...
Extremely wide blade opening. Excellent bio and MRI compatibility. Lot number on each clip. Long reliable history. Deflected large type, opening width 7.0 mm and length 5 mm....
Extremely wide blade opening. Excellent bio and MRI compatibility. Lot number on each clip. Long reliable history. Deflected large type, opening width 9.0 mm and length 7.5 mm....
Medicine Products: